Clearmind Medicine Aktie - CMND

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

1,3513

Gebot

1,25

Fragen

2,20

Volumen

45.104

1,34 Tagesbereich 1,4099

0,9512 52-Wochen-Bereich 2,30

Handelsende

1,35

Handelsbeginn

1,36

Letzte Trade

250

1.3513

(formt)

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

1.146.128

Finanzvolumen

US$ 61.823

VWAP

1,3707

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery...

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

TEL AVIV, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.1387	-9.30872483221	1.49	1.51	1.35	101313	1.38110503	CS
4	-0.125	-8.46711373027	1.4763	1.75	1.35	172657	1.499277	CS
12	-0.0487	-3.47857142857	1.4	2.18	1.14	1146128	1.67831483	CS
26	-0.3387	-20.0414201183	1.69	2.18	1.06	694070	1.59156158	CS
52	-0.0287	-2.07971014493	1.38	2.3	0.9512	1200360	1.57341151	CS
156	-161.2487	-99.1689421894	162.6	183	0.9205	1246231	8.27151449	CS
260	-161.2487	-99.1689421894	162.6	183	0.9205	1246231	8.27151449	CS

CMND - Frequently Asked Questions (FAQ)

What is the current Clearmind Medicine share price?

The current share price of Clearmind Medicine is US$ 1,3513

What is the 1 year trading range for Clearmind Medicine share price?

Clearmind Medicine has traded in the range of US$ 0,9512 to US$ 2,30 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0,764 (321,87%)	729,72M
REBNReborn Coffee Inc	US$ 3,31 (63,05%)	55,54M
FCUVFocus Universal Inc	US$ 5,87 (56,62%)	1,73M
SOPASociety Pass Inc	US$ 1,54 (56,50%)	13,82M
CYCNCyclerion Therapeutics Inc	US$ 3,92 (54,33%)	82,39M
ENVBEnveric Biosciences Inc	US$ 2,0899 (-46,41%)	1,57M
NIVFNewGenIvf Group Ltd	US$ 0,1489 (-42,51%)	14,8M
GLSTGlobal Star Acquisition Inc	US$ 8,83 (-39,10%)	23,89k
PRPHProPhase Labs Inc	US$ 0,2633 (-38,02%)	872,46k
SPGCSacks Parente Golf Inc	US$ 0,5601 (-37,86%)	7,27M
TCTMTCTM Kids IT Education Inc	US$ 0,764 (321,87%)	729,72M
NVDANVIDIA Corporation	US$ 120,07 (-3,67%)	388,54M
RIMEAlgorhythm Holdings Inc	US$ 0,02565 (5,12%)	338,75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0355 (-11,25%)	236,29M
CLEUChina Liberal Education Holdings Ltd	US$ 0,1938 (30,77%)	234,8M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Clearmind Medicine Inc (CMND)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

CMND Neueste Nachrichten

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Form POS AM - Post-Effective amendments for registration statement

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces Shareholders Meeting Results

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

CMND - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Clearmind Medicine Inc (CMND) Börsenkurse

Clearmind Medicine Inc (CMND)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

CMND Neueste Nachrichten

CMND - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen